Soros Fund Management’s Abeona Therapeutics Inc Warrant ABEOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-250,000
Closed -$851K 289
2017
Q2
$851K Hold
250,000
0.02% 121
2017
Q1
$733K Hold
250,000
0.01% 156
2016
Q4
$830K Hold
250,000
0.02% 136
2016
Q3
$813K Hold
250,000
0.02% 145
2016
Q2
$238K Hold
250,000
0.01% 164
2016
Q1
$213K Hold
250,000
﹤0.01% 215
2015
Q4
$300K Hold
250,000
0.01% 229
2015
Q3
$375K Hold
250,000
0.01% 212
2015
Q2
$475K Buy
+250,000
New +$558K ﹤0.01% 220

Other funds holding ABEOW

Soros Fund Management's ABEOW Position: Q3 2017 in Review

Soros Fund Management sold out of Abeona Therapeutics Inc Warrant (ABEOW) in Q3 2017, closing a stake of 250,000 shares — an estimated $851K sold.

Soros Fund Management first reported a position in ABEOW in Q2 2015 and held it in 9 quarters. The position peaked at $851K in Q2 2017. 4 funds tracked by Wall St. Rank hold ABEOW as of Q3 2017.

  • Soros Fund Management reported no remaining Abeona Therapeutics Inc Warrant position as of Q3 2017 after selling out during the quarter.
  • Soros Fund Management sold 250,000 Abeona Therapeutics Inc Warrant shares in Q3 2017, an estimated $851K.
  • Soros Fund Management first reported a position in Abeona Therapeutics Inc Warrant in Q2 2015 and held it in 9 quarters.
  • Soros Fund Management's Abeona Therapeutics Inc Warrant position peaked at $851K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Abeona Therapeutics Inc Warrant as of Q3 2017.

Based on Soros Fund Management's 13F filing for Q3 2017, filed 14 Nov 2017.